Measuring antibiotic availability and use in 20 low- and middle-income countries

Bulletin of the World Health Organization
Rebecca KnowlesElizabeth Tayler

Abstract

To assess antibiotic availability and use in health facilities in low- and middle-income countries, using the service provision assessment and service availability and readiness assessment surveys. We obtained data on antibiotic availability at 13 561 health facilities in 13 service provision assessment and 8 service availability and readiness assessment surveys. In 10 service provision assessment surveys, child consultations with health-care providers were observed, giving data on antibiotic use in 22 699 children. Antibiotics were classified as access, watch or reserve, according to the World Health Organization's AWaRe categories. The percentage of health-care facilities across countries with specific antibiotics available and the proportion of children receiving antibiotics for key clinical syndromes were estimated. The surveys assessed the availability of 27 antibiotics (19 access, 7 watch, 1 unclassified). Co-trimoxazole and metronidazole were most widely available, being in stock at 89.5% (interquartile range, IQR: 11.6%) and 87.1% (IQR: 15.9%) of health facilities, respectively. In contrast, 17 other access and watch antibiotics were stocked, by fewer than a median of 50% of facilities. Of the 22 699 children observed, ...Continue Reading

References

Jan 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B RoweE J Threlfall
Jun 24, 2004·Health Policy·Stefano BertozziBernhard Schwartländer
Jun 21, 2005·Emerging Infectious Diseases·John M StellingStuart B Levy
Jul 29, 2005·The Lancet Infectious Diseases·Iruka N OkekeKeith P Klugman
Nov 28, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Helen W BoucherJohn Bartlett
Jan 14, 2009·Journal of Clinical Pharmacy and Therapeutics·R KumarL Jeyaseelan
Oct 18, 2011·Tropical Medicine & International Health : TM & IH·C E Vialle-ValentinD Ross-Degnan
Dec 19, 2013·Bulletin of the World Health Organization·Kathryn O'NeillTies Boerma
Feb 4, 2014·Pediatrics·Louise Elaine VazJonathan A Finkelstein
Apr 24, 2014·Annals of Clinical Microbiology and Antimicrobials·Mohitosh BiswasNelufar Yasmen
Mar 4, 2015·Ethiopian Journal of Health Sciences·Joseph FadareOlatunde Ogundare
Mar 31, 2015·Expert Review of Anti-infective Therapy·Rabiatul Salmi Md RezalBrian Godman
Nov 26, 2015·Lancet·Ramanan LaxminarayanSally Davies
Dec 17, 2015·Bulletin of the World Health Organization·Steven J HoffmanJohn-Arne Røttingen
Mar 10, 2016·Journal of Infection and Public Health·Retnosari AndrajatiSudibyo Supardi
Jan 6, 2017·Bulletin of the World Health Organization·Elizabeth T RogawskiRichard L Guerrant
Jan 25, 2017·The Journal of Antimicrobial Chemotherapy·Michael PadgetUNKNOWN BIRDY Study Group
May 20, 2017·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C PulciniM Sharland
Jul 29, 2017·BMJ Open·Christelle EliasNicola Magrini
Jan 6, 2018·The Lancet Infectious Diseases·Mike SharlandUNKNOWN 21st WHO Expert Committee on Selection and Use of Essential Medicines
Mar 28, 2018·Proceedings of the National Academy of Sciences of the United States of America·Eili Y KleinRamanan Laxminarayan
Mar 23, 2019·BMJ Global Health·Charlotte JacksonMike Sharland
May 16, 2019·The Pan African Medical Journal·Erick Alexander MboyaJames Samwel Ngocho

❮ Previous
Next ❯

Citations

Aug 4, 2020·Bulletin of the World Health Organization·Grace LiMike Sharland

❮ Previous
Next ❯

Software Mentioned

AWaRe

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.